GRP
ESPR

Global Retirement Partners’s Esperion Therapeutics ESPR Stock Holding History

Global Retirement Partners’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,448
Closed -$4.04K – 3689
2024
Q3 		$4.04K Hold
2,448
– – ﹤0.01% 2667
2024
Q2 		$5.43K Hold
2,448
– – ﹤0.01% 2578
2024
Q1 		$6.56K Buy
+2,448
New +$5.95K ﹤0.01% 2292

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Global Retirement Partners's ESPR Position: Q4 2024 in Review

Global Retirement Partners sold out of Esperion Therapeutics (ESPR) in Q4 2024, closing a stake of 2,448 shares — an estimated $4.04K sold.

Global Retirement Partners first reported a position in ESPR in Q1 2024 and held it in 3 quarters. The position peaked at $6.56K in Q1 2024. 189 funds tracked by Wall St. Rank hold ESPR as of Q4 2024.

  • Global Retirement Partners reported no remaining Esperion Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Global Retirement Partners sold 2,448 Esperion Therapeutics shares in Q4 2024, an estimated $4.04K.
  • Global Retirement Partners first reported a position in Esperion Therapeutics in Q1 2024 and held it in 3 quarters.
  • Global Retirement Partners's Esperion Therapeutics position peaked at $6.56K in Q1 2024.
  • 189 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.